Patents

7.

6.

5.

4.

3.

2.

1.

Zhen Gu, Jicheng Yu, and Guojun Chen, “Microneedle-Array Patches With Glucose-Responsive Matrix For Closed-Loop Insulin Delivery”, PCT/US2019/048063, 2019 (Accepted into the U.S. Food and Drug Administration's “Emerging Technology Program”)

 

Shaoqin Gong, Kris Saha, Guojun Chen, Amr A. Abdeen, Yuyuan Wang, and Ruosen Xie, “Nanocapsule Delivery System for Ribonucleoproteins”, US20190099381A1, 2021 (Granted)

 

Shaoqin Gong, and Guojun Chen, “Unimolecular Nanoparticles for Efficient Delivery of Therapeutic RNA”, US20180140557A1, 2021 (Granted)


Craig C. Kent, Shaoqin Gong, Xudong Shi, Guojun Chen, and Lianwang Guo, “Perivascular Drug Delivery System”, US20180042844A1, 2020 (Granted)

Craig K. Kent, Shaoqin Gong, Lianwang Guo, Guojun Chen, and Bowen Wang, “Biomimetic Vesicles And Uses Thereof”, US20210205473A1, 2022 (Granted).

Richard E. Wirz, Zhen Gu, Zhitong Chen, and Guojun Chen, "Portable Cold Atmospheric Plasma Delivery Device And Methods Of Use", PCT/US20/064361, 2021 (Pending)


Zhen Gu, Richard E. Wirz, Guojun Chen, and Zhitong Chen, “Transdermal Microneedle-Mediated Immune Checkpoint Blockade Therapy”, PCT/ US20/064361, 2020 (Pending).